Google
×
About us. reMYND is a clinical stage company developing treatments for Alzheimer's, Huntington's, epilepsy and other diseases caused by cellular dysfunction. It ...

reMYND

(1) Research institute in Leuven, Belgium
Address: Gaston Geenslaan 1, 3001 Leuven, Belgium
Hours: Closed ⋅ Opens 8:30 AM
Phone: +32 16 75 14 20 ⋅ +32 16 75 14 21

See results about

Feb 21, 2021 · reMYND NV is a dynamic biotech company located in Leuven (Belgium) that actively drives R&D in the field of protein misfolding diseases, ...
reMYND nv is a biotech company focusing on disorders of the nervous system, and already has its lead compound in phase II clinical development for ...
reMYND actively drives the development of disease modifying treatments against Alzheimer's disease (AD), Parkinson's disease (PD), and diabetes, ...
reMYND focusses pre-clinical development on 2 compounds active against PD and 3 compounds active against Tau in AD. We have demonstrated full disease-modifying.
We specialize in the mental well-being of both kids and adults. Our team of highly-skilled and experienced Psychologist, Special Educators, Counsellors, ...
NV reMYND a Leuven University spin-off, is driving the development of treatments against protein misfolding disorders such as Alzheimer's disease, ...